did serena williams really use glp 1 is opening up about her experience with GLP-1 medications. The 43-year-old tennis star has lost 31 pounds on the drug Zepbound, a type of medication typically prescribed for diabetes and Serena Williams went public, saying

An analysis of the ELIXA trial data indicated that short-term GLP-1RAs may also have renal protective effects, analogous to long-acting GLP-1RAs [47]

When caloric intake is substantially reduceda common occurrence given semaglutide's potent effects on appetite and satietythe body shifts from primarily using glucose for energy to breaking down stored fat

Primary outcomes included (1) hepatocellular carcinoma (HCC) and cirrhosis, and (2) cardiovascular disease (CVD), chronic kidney disease (CKD), and non-liver cancer

Training continued without compromise in zone 2

Thankfully, she was already at Wellstar Kennestone Regional Medical Center receiving the compassionate care shed been seeking to address a long list of symptoms